Pluslife Biotech Co., Ltd.

Guangzhou Pluslife Biotech Co., Ltd. established in Guangzhou, China in 2017. With our R&D team that combines experienced and talented researching and developing personnel that more than 60% of them are certificated Ph.Ds or Masters, our team satisfies the needs of applying cutting-edge genetic technologies to develop an independent and innovative molecular POCT diagnostic system that provides complete and economic solutions to our users.

Based on the self-developed isothermal molecular detection technology, Pluslife's Molecular POCT detection system can be used in comprehensive application scenarios such as human respiratory infections, STD infections, genotype detection, pet disease detection, and expanded molecular detection to clinics and individuals' family-care uses.

For several years, Guangzhou Pluslife Biotech dedicates in our mission of “Improve human life by biotechnology “ and focus on innovative R&D of the integrated POCT molecular detection system. Pluslife seeks to constant optimization of our products for detecting infectious disease, including respiration disease, STD and veterinary testing , and help the public to confronting varies challenges. Since the outbreak of the Coronavirus disease (COVID-19) pandemic, Pluslife’s detection system has enhanced on-site nucleic acid testing solutions in dozens of nations around the globe, with accuracy, rapidity and cost-effectiveness, and achieving our mission of improving human life in this global fight against the plague.

Pluslife hopes to constantly providing innovative universal diagnose solutions for infectious disease, growing to be the guardian for public welfare.

Core Culture: Benefit life, innovate safety

Pluslife Spirit: Innovator, Truth-seeker, Winner